Hartmann’s Solution compound Sodium Lactate

Hartmann’s Solution is an intravenous electrolyte solution containing sodium lactate 60% along with potassium chloride, sodium chloride, and calcium chloride dihydrate. It is supplied as a sterile solution for injection and is classified as a volume expander used to replace extracellular fluid. The product is marketed in the European Union and requires a prescription. It provides essential electrolytes to support physiological balance and is utilized in settings for fluid resuscitation.

Hartmann’s Solution is indicated for conditions where fluid and electrolyte replacement is required.

- Treatment of dehydration caused by illness or excessive fluid loss - Management of hypovolemia due to bleeding or trauma - Correction of electrolyte imbalances, especially low sodium or potassium - Peri‑operative fluid management to maintain intravascular volume - Supportive therapy for burn patients and extensive skin loss

Hartmann’s Solution may be associated with both mild and more serious adverse reactions.

Common: - Transient pain or irritation at the infusion site - Mild nausea or vomiting - Headache or dizziness - Mild metabolic alkalosis due to lactate metabolism - Flushing or warmth sensation - Temporary elevation of serum potassium (hyperkalemia)

Serious: - Severe hyperkalemia leading to cardiac arrhythmia - Anaphylactic or severe allergic reaction - Pulmonary edema from fluid overload - Severe metabolic acidosis if lactate metabolism is impaired - Life‑threatening arrhythmias - Acute kidney injury secondary to electrolyte disturbances

When using Hartmann’s Solution, clinicians should consider several safety factors.

- Assess baseline electrolyte levels and renal function before initiation - Monitor serum potassium, sodium, calcium, and lactate during infusion - Adjust infusion rate in patients with heart failure or risk of fluid overload - Use caution in individuals with liver disease, as lactate metabolism may be impaired - Avoid rapid large-volume boluses unless clinically indicated - Verify compatibility with other IV medications before co‑administration - Document any allergic reactions or prior sensitivities to lactate solutions

Hartmann’s Solution can interact with certain medications and clinical conditions.

Avoid: - Concurrent administration of potassium‑sparing diuretics or high‑dose potassium supplements, which may exacerbate hyperkalemia - Co‑infusion with calcium‑containing solutions without proper flushing, risking precipitation - Use with drugs that cause metabolic acidosis, as lactate may worsen acid‑base balance

Use with caution: - ACE inhibitors or ARBs, which can affect potassium homeostasis - Beta‑blockers, which may mask signs of hypoglycemia in diabetic patients receiving the solution - Sodium‑containing medications, to prevent excessive sodium load - Blood transfusions, requiring careful monitoring of electrolyte shifts